Girard, Nicolas <br/><br/>
Is neoadjuvant chemoradiotherapy a feasible strategy for stage IIIA-N2 non-small cell lung cancer? Mature results of the randomized IFCT-0101 phase II trial.  [electronic resource] 

 -  Lung cancer (Amsterdam, Netherlands)  Jul 2010 
 - 86-93 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1872-8332 
<br/><br/><label>Standard No.: </label>10.1016/j.lungcan.2009.10.003  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Combined Chemotherapy Protocols<br/>Carboplatin--administration & dosage<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>Cisplatin--administration & dosage<br/>Deoxycytidine--administration & dosage<br/>Feasibility Studies<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Lung Neoplasms--drug therapy<br/>Male<br/>Middle Aged<br/>Neoadjuvant Therapy<br/>Neoplasm Recurrence, Local<br/>Neoplasm Staging<br/>Paclitaxel--administration & dosage<br/>Survival Analysis<br/>Vinblastine--administration & dosage<br/>Vinorelbine<br/>Gemcitabine